Free Trial

Cencora (COR) Competitors

Cencora logo
$274.97 +1.00 (+0.37%)
As of 12:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

COR vs. MCK, CAH, HSIC, PDCO, OMI, HLF, NUS, COSM, HWH, and MEDS

Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and TRxADE HEALTH (MEDS).

Cencora vs.

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, community ranking, valuation and earnings.

In the previous week, McKesson had 3 more articles in the media than Cencora. MarketBeat recorded 37 mentions for McKesson and 34 mentions for Cencora. McKesson's average media sentiment score of 1.53 beat Cencora's score of 1.41 indicating that McKesson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cencora
27 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
McKesson
35 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Cencora has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 10.8% of Cencora shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Cencora0.46% 328.62% 4.23%
McKesson 0.82%-181.26%5.34%

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cencora$638.56M83.50$1.51B$7.0339.11
McKesson$344.58B0.24$3.00B$21.8430.45

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays out 31.3% of its earnings in the form of a dividend. McKesson pays out 13.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and McKesson has raised its dividend for 17 consecutive years.

Cencora presently has a consensus target price of $280.20, indicating a potential upside of 1.90%. McKesson has a consensus target price of $649.36, indicating a potential downside of 2.35%. Given Cencora's higher possible upside, research analysts clearly believe Cencora is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cencora
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
McKesson
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.93

McKesson received 226 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.27% of users gave McKesson an outperform vote while only 65.30% of users gave Cencora an outperform vote.

CompanyUnderperformOutperform
CencoraOutperform Votes
747
65.30%
Underperform Votes
397
34.70%
McKessonOutperform Votes
973
74.27%
Underperform Votes
337
25.73%

Summary

McKesson beats Cencora on 15 of the 22 factors compared between the two stocks.

Remove Ads
Get Cencora News Delivered to You Automatically

Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COR vs. The Competition

MetricCencoraDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$53.36B$20.62B$5.64B$19.41B
Dividend Yield0.82%1.29%4.57%3.75%
P/E Ratio39.1411.7023.1233.07
Price / Sales83.509.57385.6726.50
Price / Cash12.2512.9538.1617.54
Price / Book147.0431.536.884.53
Net Income$1.51B$785.39M$3.20B$1.02B
7 Day Performance3.02%-2.97%-2.58%-1.09%
1 Month Performance8.47%-7.60%1.93%-3.84%
1 Year Performance13.18%-16.29%9.78%3.64%

Cencora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
3.9826 of 5 stars
$274.97
+0.4%
$280.20
+1.9%
+12.1%$53.36B$638.56M39.1442,000Insider Trade
Positive News
MCK
McKesson
4.0448 of 5 stars
$661.56
+0.1%
$649.36
-1.8%
+23.5%$82.91B$344.58B30.2975,000Positive News
CAH
Cardinal Health
4.5331 of 5 stars
$133.25
+1.0%
$139.36
+4.6%
+21.6%$32.19B$222.28B24.8648,900Positive News
HSIC
Henry Schein
4.3119 of 5 stars
$70.78
+2.0%
$81.10
+14.6%
-7.7%$8.79B$12.67B29.1322,000Short Interest ↓
PDCO
Patterson Companies
3.8632 of 5 stars
$31.20
+0.1%
$26.57
-14.8%
+12.5%$2.76B$6.51B18.247,600Analyst Forecast
OMI
Owens & Minor
4.8034 of 5 stars
$9.27
+2.9%
$13.75
+48.4%
-69.6%$715.69M$10.70B-14.2513,700Short Interest ↓
HLF
Herbalife
4.6449 of 5 stars
$8.10
-4.0%
$12.00
+48.2%
-9.0%$820.36M$4.99B3.259,200
NUS
Nu Skin Enterprises
2.9507 of 5 stars
$7.36
-4.6%
$6.88
-6.5%
-45.4%$365.71M$1.73B-2.493,700
COSM
Cosmos Health
2.4782 of 5 stars
$0.50
+3.7%
N/A-32.7%$11.72M$56.04M-0.21100Short Interest ↓
Positive News
HWH
HWH International
N/A$1.46
-7.6%
N/A-71.8%$9.06MN/A0.00N/AShort Interest ↓
Gap Down
MEDS
TRxADE HEALTH
N/A$2.01
+18.9%
N/A-82.1%$2.83M$7.45M0.0050Gap Up
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NYSE:COR) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners